Gabelli & Co Investment Advisers’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,651	Closed	-$283K	–	514
2021 Q3	$283K	Hold	8,651	–	–	0.03%	293
2021 Q2	$361K	Hold	8,651	–	–	0.04%	256
2021 Q1	$566K	Sell	8,651 -1,301	-13%	-$90.8K	0.07%	181
2020 Q4	$654K	Sell	9,952 -3,925	-28%	-$256K	0.1%	145
2020 Q3	$754K	Buy	13,877 +4,539	+49%	+$347K	0.14%	114
2020 Q2	$891K	Buy	9,338 +57	+0.6%	+$4.25K	0.2%	85
2020 Q1	$476K	Buy	+9,281	New	+$970K	0.07%	106

Other funds holding SRGA

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

CLG

Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Gabelli & Co Investment Advisers's SRGA Position: Q4 2021 in Review

Gabelli & Co Investment Advisers sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 8,651 shares — an estimated $283K sold.

Gabelli & Co Investment Advisers first reported a position in SRGA in Q1 2020 and held it in 7 quarters. The position peaked at $891K in Q2 2020. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

Gabelli & Co Investment Advisers reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 8,651 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $283K.
Gabelli & Co Investment Advisers first reported a position in Surgalign Holdings, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Gabelli & Co Investment Advisers's Surgalign Holdings, Inc. Common Stock position peaked at $891K in Q2 2020.
72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2021, filed 11 Feb 2022.